Figure | Statistical test | Independent variable (s) | Sample size | Statistics | Observed power | Post hoc comparison (if applicable) | Post hoc statistics |
---|---|---|---|---|---|---|---|
3 | Two-way ANOVA | Brain region (cortex, hypothalamus, hippocampus)Treatment (Intact + aCSF, OVX + aCSF, OVX + ICI, OVX + Let) | Cortex:Intact + aCSF n = 4OVX + aCSF n = 4OVX + ICI n = 4OVX + Let n = 4Hypothalamus:Intact + aCSF n = 4OVX + aCSF n = 4OVX + ICI n = 4OVX + Let n = 4Hippocampus:Intact + aCSF n = 4OVX + aCSF n = 4OVX + ICI n = 3OVX + Let n = 4 | ||||
Main effect of brain region | F(2,35) = 0.031; p = 0.970 | 0.054 | |||||
Main effect of treatment | F(3,35) = 5.448; *p = 0.004 | 0.909 | Intact + aCSF vs OVX + aCSF | p = 0.527 | |||
OVX + aCSF vs OVX + ICI | *p = 0.002 | ||||||
OVX + aCSF vs OVX + Let | *p = 0.030 | ||||||
Brain region × treatment interaction | F(6,35) = 1.015; p = 0.432 | 0.345 |
Let, Letrozole.
*Significant.